Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass. This evidence concerns the gene FGF19 and metabolic dysfunction-associated steatotic liver disease.